EMEA (Europe, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2017 Forecast to 2022

January 2018 | 123 pages | ID: E2297059602EN
GlobalInfoResearch

Abstracts

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

SCOPE OF THE REPORT:

This report focuses on the Intravenous Immunoglobulin (IVIg) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Baxter
• Grifols
• CSL
• Octapharma
• Biotest
• Kedrion
• Hualan Bio
• CNBG
• Shanghai RAAS
• CBPO
• LFB Group
• BPL
• Sichuan Yuanda Shuyang

Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers

• IVIg Liquid
• IVIg Powder

Market Segment by Applications, can be divided into

• Immunodeficiency
• Autoimmune Disease
• Acute Infection

There are 13 Chapters to deeply display the EMEA Intravenous Immunoglobulin (IVIg) market.

Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous Immunoglobulin (IVIg), with sales, revenue, and price of Intravenous Immunoglobulin (IVIg), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Intravenous Immunoglobulin (IVIg), for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Intravenous Immunoglobulin (IVIg) research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 Market Analysis by Type
  1.2.1 IVIg Liquid
  1.2.2 IVIg Powder
1.3 Market Analysis by Applications
  1.3.1 Immunodeficiency
  1.3.2 Autoimmune Disease
  1.3.3 Acute Infection
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Baxter
  2.1.1 Business Overview
  2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
  2.2.1 Business Overview
  2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
  2.3.1 Business Overview
  2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Octapharma
  2.4.1 Business Overview
  2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biotest
  2.5.1 Business Overview
  2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kedrion
  2.6.1 Business Overview
  2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Bio
  2.7.1 Business Overview
  2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 CNBG
  2.8.1 Business Overview
  2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Shanghai RAAS
  2.9.1 Business Overview
  2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CBPO
  2.10.1 Business Overview
  2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 LFB Group
  2.11.1 Business Overview
  2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BPL
  2.12.1 Business Overview
  2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sichuan Yuanda Shuyang
  2.13.1 Business Overview
  2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer
3.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer
3.3 EMEA Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share
  3.4.2 Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET ANALYSIS BY REGIONS

4.1 EMEA Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Intravenous Immunoglobulin (IVIg) Sales by Regions (2012-2017)
  4.1.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue by Regions (2012-2017)
4.2 Europe Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
4.3 Middle East Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
4.4 Africa Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)

5 EUROPE INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
  5.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
  5.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
  5.1.3 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  5.1.4 France Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  5.1.5 UK Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  5.1.6 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  5.1.7 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  5.1.8 Turkey Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
5.2 Europe Intravenous Immunoglobulin (IVIg) Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
  5.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
5.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
5.4 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

6 MIDDLE EAST INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
  6.1.2 Middle East Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  6.1.4 Israel Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  6.1.5 UAE Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  6.1.6 Iran Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
6.2 Middle East Intravenous Immunoglobulin (IVIg) Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
6.3 Middle East Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
6.4 Middle East Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

7 AFRICA INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
  7.1.1 Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
  7.1.2 Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
  7.1.3 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  7.1.4 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  7.1.5 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
  7.1.6 Algeria Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
7.2 Middle East Intravenous Immunoglobulin (IVIg) Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
7.3 Middle East Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
7.4 Middle East Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

8 EMEA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SEGMENT BY TYPE

8.1 EMEA Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
8.2 IVIg Liquid Sales Growth and Price
  10.2.1 EMEA IVIg Liquid Sales Growth (2012-2017)
  10.2.2 EMEA IVIg Liquid Price (2012-2017)
8.3 IVIg Powder Sales Growth and Price
  10.3.1 EMEA IVIg Powder Sales Growth (2012-2017)
  10.3.2 EMEA IVIg Powder Price (2012-2017)

9 EMEA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SEGMENT BY APPLICATION

9.1 EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
9.2 Immunodeficiency Sales Growth (2012-2017)
9.3 Autoimmune Disease Sales Growth (2012-2017)
9.4 Acute Infection Sales Growth (2012-2017)

10 EMEA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET FORECAST (2017-2022)

10.1 EMEA Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2017-2022)
10.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2017-2022)
  10.2.1 Europe Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.1.2 France Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.1.3 UK Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.1.4 Russia Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.1.5 Italy Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.1.6 Turkey Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.2.2 Israel Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.2.3 UAE Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.2.4 Iran Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.3.2 Nigeria Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.3.3 Egypt Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
    10.2.3.4 Algeria Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
10.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2017-2022)
10.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Intravenous Immunoglobulin (IVIg) Picture
Table Product Specifications of Intravenous Immunoglobulin (IVIg)
Figure EMEA Sales Market Share of Intravenous Immunoglobulin (IVIg) by Types in 2016
Table Intravenous Immunoglobulin (IVIg) Types for Major Manufacturers
Figure IVIg Liquid Picture
Figure IVIg Powder Picture
Table Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications in 2016
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Figure Germany Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure France Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure UK Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2012-2022)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Intravenous Immunoglobulin (IVIg) Type and Applications
Table Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Intravenous Immunoglobulin (IVIg) Type and Applications
Table Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Intravenous Immunoglobulin (IVIg) Type and Applications
Table CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Intravenous Immunoglobulin (IVIg) Type and Applications
Table Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Intravenous Immunoglobulin (IVIg) Type and Applications
Table Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Intravenous Immunoglobulin (IVIg) Type and Applications
Table Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Intravenous Immunoglobulin (IVIg) Type and Applications
Table Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG Intravenous Immunoglobulin (IVIg) Type and Applications
Table CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Type and Applications
Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Intravenous Immunoglobulin (IVIg) Type and Applications
Table CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LFB Group Basic Information, Manufacturing Base and Competitors
Table LFB Group Intravenous Immunoglobulin (IVIg) Type and Applications
Table LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Intravenous Immunoglobulin (IVIg) Type and Applications
Table BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Type and Applications
Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table EMEA Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales by Regions (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions in 2012
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions in 2016
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue by Regions (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2012
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2016
Figure Europe Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2012
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2016
Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2012
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure Germany Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure France Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure UK Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Russia Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Italy Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Turkey Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Share by Application (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2012
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2016
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2012
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Israel Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure UAE Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Iran Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Share by Application (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2012
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2016
Table Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2012
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Figure Algeria Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Share by Application (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2012-2017)
Figure EMEA IVIg Liquid Sales Growth (2012-2017)
Figure EMEA IVIg Liquid Price (2012-2017)
Figure EMEA IVIg Powder Sales Growth (2012-2017)
Figure EMEA IVIg Powder Price (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Share by Application (2012-2017)
Figure EMEA Immunodeficiency Sales Growth (2012-2017)
Figure EMEA Autoimmune Disease Sales Growth (2012-2017)
Figure EMEA Acute Infection Sales Growth (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Market Share Forecast by Regions (2017-2022)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions (2017-2022)
Figure Germany Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure France Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure UK Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Russia Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Italy Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Turkey Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Israel Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure UAE Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Iran Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Nigeria Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Egypt Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Figure Algeria Intravenous Immunoglobulin (IVIg) Sales Forecast 2017-2022
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List